Rhonda B. Levin

L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor.

Joseph P. Vacca, Bruce D. Dorsey, William A. Schleif et al. · Proceedings of the National Academy of Sciences · 1994 · 526 citations · Full text

Immunology, Cell Culture, Pharmacotherapy +19

L-735,524: The Design of a Potent and Orally Bioavailable HIV Protease Inhibitor

Bruce D. Dorsey, Rhonda B. Levin, Stacey L. McDaniel et al. · Journal of Medicinal Chemistry · 1994 · 408 citations · Full text

A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active site

M. Katharine Holloway, Jenny Wai, Thomas A. Halgren et al. · Journal of Medicinal Chemistry · 1995 · 228 citations · Full text

Molecular Biology, Antiviral Drug, Energy Minimization +18

Inhibitors of hepatitis C virus NS3·4A protease 2. Warhead SAR and optimization

Robert B. Perni, J. PITLIK, Shawn Britt et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 62 citations · Full text

Immunology, Antiviral Drug Development, Hepatitis +9

Identification of MK-944a:  A Second Clinical Candidate from the Hydroxylaminepentanamide Isostere Series of HIV Protease Inhibitors

Bruce D. Dorsey, Colleen M. McDonough, Stacey L. McDaniel et al. · Journal of Medicinal Chemistry · 2000 · 55 citations · Full text

Immunology, Pharmacotherapy, Antiviral Drug +17